CoChat

Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial

Open access
Ghio, Stefano, Scelsi, Laura, Latini, Roberto, Masson, Serge, Eleuteri, Ermanno, Palvarini, Michela, Vriz, Olga, Pasotti, Michele, Gorini, Marco, Marchioli, Roberto, Maggioni, Aldo, Tavazzi, Luigi, for the GISSI-HF investigators · 2010 · European Journal of Heart Failure
Cited by 82

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aims: The GISSI-HF trial showed that n-3 polyunsaturated fatty acids (PUFA), but not rosuvastatin, reduce morbidity and mortality in patients with symptomatic heart failure (HF) of any cause. The aim of this echocardiographic substudy of GISSI-HF was to investigate the effects of n-3 PUFA and of rosuvastatin on left ventricular (LV) function in such patients. Methods and results: Six hundred and eight chronic HF patients were randomized to n-3 PUFA (n = 312) or placebo (n = 296); a second randomization was performed to rosuvastatin (n = 212) or placebo (n = 207). Echocardiographic examinations were recorded at baseline and at 1, 2, and 3 years; offline analysis was performed by a core laboratory to ensure consistent quantitative analysis. Baseline LV ejection fraction (EF) was 30% (95%CI 29–31). Left ventricular ejection fraction increased with n-3 PUFA by 8.1% at 1 year, 11.1% at 2 years, and 11.5% at 3 years vs. 6.3% at 1 year, 8.2% at 2 years, and 9.9% at 3 years in the placebo group (P = 0.0050). No other echocardiographic parameter changed significantly. Rosuvastatin effects were not statistically significant. Conclusion: n-3 PUFA can provide a small but statistically significant advantage in terms of LV function in patients with symptomatic HF of any aetiology, already treated with recommended therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfq172

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 82

Metadata

Authors
Ghio, S., Scelsi, L., Latini, R., Masson, S., Eleuteri, E., Palvarini, M., Vriz, O., Pasotti, M., Gorini, M., Marchioli, R., Maggioni, A., Tavazzi, L., & for the GISSI-HF investigators
Venue
European Journal of Heart Failure
Published
2010-12-01
Volume
12
Issue
12
Pages
1345-1353
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2020223480
Cited by
82
References
7
FWCI
8.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial. https://app.cochat.ai/papers/10.1093/eurjhf/hfq172
The paper
Ghio, S., Scelsi, L., Latini, R., Masson, S., Eleuteri, E., Palvarini, M., Vriz, O., Pasotti, M., Gorini, M., Marchioli, R., Maggioni, A., Tavazzi, L., & for the GISSI-HF investigators. (2010). Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfq172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.